Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 14.35% is 746% above its 5-year average of -2.22%, near the high end of its 5-year range (-32.34%–14.35%).
As of the fiscal period ended Tuesday, June 30, 2026. 51.69% above its 12-month average of 9.46%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 14.35%.
RETURN ON EQUITY (ROE)
14.35%
RETURN ON EQUITY (ROE) AVG TTM
9.46%
RETURN ON EQUITY (ROE) AVG 3Y
-3.55%
RETURN ON EQUITY (ROE) AVG 5Y
-2.22%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+51.69%
CURRENT VS 3Y AVG
+504.32%
CURRENT VS 5Y AVG
+746.18%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.32%
median of 332 covered companies
CURRENT VS SECTOR MEDIAN
+150.68%
vs the sector median at left
BrightSpring Health Services, Inc. Common Stock
Market Cap
$12.17B
Return on Equity (ROE)
14.35%
TTM Avg
9.46%
3Y Avg
-3.55%
5Y Avg
-2.22%
Market Cap
$12.00B
Return on Equity (ROE)
23.91%
TTM Avg
22.63%
3Y Avg
21.83%
5Y Avg
21.13%
Market Cap
$12.49B
Return on Equity (ROE)
10.49%
TTM Avg
6.83%
3Y Avg
5.29%
5Y Avg
3.21%
Market Cap
$12.52B
Return on Equity (ROE)
-17.13%
TTM Avg
-12.46%
3Y Avg
-8.76%
5Y Avg
-1.37%
Market Cap
$11.47B
Return on Equity (ROE)
N/A
TTM Avg
329.18%
3Y Avg
200.63%
5Y Avg
164.66%
Market Cap
$12.89B
Return on Equity (ROE)
3.51%
TTM Avg
5.40%
3Y Avg
5.85%
5Y Avg
7.17%
Market Cap
$12.95B
Return on Equity (ROE)
N/A
TTM Avg
35.81%
3Y Avg
39.37%
5Y Avg
-92.14%
Market Cap
$11.36B
Return on Equity (ROE)
8.63%
TTM Avg
6.23%
3Y Avg
8.78%
5Y Avg
10.01%
Market Cap
$13.19B
Return on Equity (ROE)
7.78%
TTM Avg
17.97%
3Y Avg
19.27%
5Y Avg
21.22%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $12.17B | 14.35% | 9.46% | -3.55% | -2.22% |
| Encompass Health Corporation (EHC)vs › | $12.00B | 23.91% | 22.63% | 21.83% | 21.13% |
| Penumbra, Inc. (PEN)vs › | $12.49B | 10.49% | 6.83% | 5.29% | 3.21% |
| Baxter International Inc. (BAX)vs › | $12.52B | -17.13% | -12.46% | -8.76% | -1.37% |
| DaVita Inc. (DVA)vs › | $11.47B | N/A | 329.18% | 200.63% | 164.66% |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 3.51% | 5.40% | 5.85% | 7.17% |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | N/A | 35.81% | 39.37% | -92.14% |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 8.63% | 6.23% | 8.78% | 10.01% |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 7.78% | 17.97% | 19.27% | 21.22% |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $11.12B | 1.15% | 6.63% | 4.94% | 6.51% |
ROE
14.4%
ROA
4.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 14.35% |
| 2026-03-31 | 11.90% |
| 2025-12-31 | 10.17% |
| 2025-09-30 | 7.13% |
| 2025-06-30 | 3.76% |
| 2025-03-31 | 3.39% |
| 2024-12-31 | -1.10% |
| 2024-09-30 | -2.51% |
| 2024-06-30 | -10.19% |
| 2024-03-31 | -11.42% |
| 2023-12-31 | -26.44% |
| 2023-09-30 | -32.34% |
| 2023-06-30 | -12.85% |
| 2022-12-31 | -7.14% |
| 2021-12-31 | 6.49% |
| 2021-09-30 | 4.62% |
| 2021-06-30 | 4.43% |
| 2021-03-31 | 3.75% |
| 2020-12-31 | 2.95% |
| 2020-03-31 | -3.25% |
